
Omee Penta Penta IV 40mg Injection
Marketer
Alkem Laboratories Ltd
Salt Composition
Pantoprazole (40mg)
Overview Omee Penta Penta IV 40mg Injection
Injected Omee Penta 40mg (Penta IV) diminishes gastric acid production. It treats stomach and intestinal conditions like acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, relieving symptoms and fostering healing. This intravenous medication also prevents stress ulcers in critically ill patients and is pre-anesthetically administered to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), it's intravenously administered by a medical professional only when deemed superior to oral forms. Dosage is condition- and response-dependent, determined by your physician. Continue the prescribed course, regardless of symptom resolution. Smaller, more frequent meals and avoidance of caffeine, spices, and fatty foods enhance treatment efficacy. Common, typically mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, stomach pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects necessitate medical consultation. Prolonged use (over a year) may increase bone fracture risk, particularly at higher doses. Discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your doctor. This injection is unsuitable for individuals with severe liver disease, those on HIV medications, those with prior allergic reactions to similar drugs, or those with osteoporosis. Pregnant or breastfeeding individuals should seek medical advice before use. Alcohol consumption should be avoided due to its acid-stimulating effects. Refrain from operating machinery if dizziness or drowsiness occurs.
Uses of Omee Penta Penta IV 40mg Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Omee Penta Penta IV 40mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Omee Penta Penta IV 40mg Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Omee Penta Penta IV 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Omee Penta Penta IV 40mg Injection works:
Penta IV 40mg Injection, containing Omee Penta, is a proton pump inhibitor that decreases stomach acid production, thereby alleviating heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Omee Penta Penta IV 40mg Injection is not advised due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Administering Omee Penta Penta IV 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Omee Penta Penta IV 40mg Injection without significant harm to their infants. Available human data indicates minimal risk to the nursing baby.
DrivingCONSULT YOUR DOCTOR
The effect of Omee Penta Penta IV 40mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Omee Penta IV 40mg Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
Patients with severe hepatic impairment should use Omee Penta Penta IV 40mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Omee Penta Penta IV 40mg Injection :
Omitting a scheduled dose of Omee Penta IV 40mg Injection requires immediate medical advice.
Facts to Know About Omee Penta Penta IV 40mg Injection
| Label | Value |
|---|---|
| Type of Compound | Benzimidazole sulfone compound |
| Addictive | None. |
| Medication Classification | Stomach and intestinal |
| Mechanism of Action | Gastric acid secretion suppressants |
